Harper Molly
Insider CIK 1871470 · CPRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,894 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,414 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 23,248 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,524 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 12,500 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 3,694 | $31.50 | $116.4K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 127,163 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 3,694 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-12 | 2025-12-16 | 20,000 | — | $0 | 128,497 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-12-12 | 2025-12-16 | 6,746 | $23.06 | $155.6K | 2,360 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-12 | 2025-12-16 | 20,000 | $5.78 | $115.6K | 29,106 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-12-12 | 2025-12-16 | 15,527 | $23.20 | $360.2K | 13,579 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-12-12 | 2025-12-16 | 4,473 | $23.73 | $106.1K | 9,106 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 148,497 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 9,106 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 149,910 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 7,693 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 150,857 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 145,389 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 127,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 6,746 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 131,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 2,746 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 132,607 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 1,413 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-11-27 | 2024-11-29 | 17,500 | — | $0 | 134,020 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-11-27 | 2024-11-29 | 17,500 | $5.78 | $101.2K | 17,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-11-27 | 2024-11-29 | 17,500 | $22.00 | $385.0K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 2,841 | — | $0 | 151,520 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 23,248 | — | $0 | 148,679 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-06-03 | 2024-06-05 | 5,333 | $16.30 | $86.9K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 125,431 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 5,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 129,431 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 1,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-15 | 2023-12-19 | 10,000 | — | $0 | 130,764 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-15 | 2023-12-19 | 10,000 | $5.78 | $57.8K | 10,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-12-15 | 2023-12-19 | 4,000 | $14.43 | $57.7K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-12-15 | 2023-12-19 | 10,000 | $14.37 | $143.7K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 4,240 | — | $0 | 140,764 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 29,524 | — | $0 | 136,524 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 107,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 4,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 4,000 | — | $0 | 111,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 15,000 | — | $0 | 107,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 12,000 | — | $0 | 92,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 20,000 | — | $0 | 80,000 | SEC↗ |